First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors
Clinical trial NCT02937116 · COMPLETED
Trial details
- NCT number
- NCT02937116
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-19
- Primary completion
- 2020-09-30
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.